Rapid Assessment of Brain Bleeding from Head Injury by New Device
The AHEAD 300 hand-held EEG device, approved by the U.S. Food and Drug Administration in 2016, was the subject of a clinical trial conducted among adults in 11 hospitals. Researchers found that the device, developed by BrainScope Company Inc., of Bethesda Maryland, can quickly rule out whether a person with a head injury is likely to have brain bleeding requiring further evaluation and treatment. The results have an accuracy rate of 97 percent. Approximately 2.5 million people arrive at the emergency room with a suspected head injury each year in the U.S. according to the Centers for Disease Control and Prevention. Most of these patients receive [...]